In discussing the mananagement of patients in the waiting list, the terms neoadjuvant treatment, bridging, downstaging and dropout should be used consistently, and on the basis of accepted selection criteria (currently MC, incorporated into the tumor-nodemetastasis [TNM] staging system as follows: T
Is the treatment of hepatocellular carcinoma on the waiting list necessary?
✍ Scribed by Pietro Majno; Riccardo Lencioni; Françoise Mornex; Nicolas Girard; Ronnie T. Poon; Daniel Cherqui
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 135 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.22391
No coin nor oath required. For personal study only.
✦ Synopsis
To summarize our knowledge of the history of HCC in patients on the waiting list.
• To summarize our knowledge of different management strategies that can be implemented.
📜 SIMILAR VOLUMES
Francisco; RFTA, radiofrequency thermal ablation; TACE, transarterial chemoembolization; UNOS, United Network for Organ Sharing. This article is based on a review of the treatment of hepatocellular carcinoma while patients are on a liver transplant waiting list that our group published in Journal of
For patients who are initially being listed for liver transplantation and for patients who are seeking to retain their active status on the wait list, the first step in the diagnostic consideration of hepatocellular carcinoma (HCC) is the accurate identification and staging of the tumors. Advances i
We analyzed global gene expression patterns of 91 human hepatocellular carcinomas (HCCs) to define the molecular characteristics of the tumors and to test the prognostic value of the expression profiles. Unsupervised classification methods revealed two distinctive subclasses of HCC that are highly a